Abingworth LLP

13 articles about Abingworth LLP

• 

  Global Roundup: Medtronic Acquires Affera, Inc to Expand Cardiac Ablation Line

  1/13/2022

  Biopharma and life sciences companies from across the globe provide updates to their businesses and pipelines.
• 

  Abingworth's $582 Million Co-Development Fund Will Propel Late-Stage Trials

  5/10/2021

  London-based venture capital fund Abingworth closed on a new Clinical Co-Development Fund now at $582 million. The fund's original target was just at $350 million.

• Abingworth raises $465m for new life sciences fund Abingworth Bioventures 8

  2/3/2021

  Oversubscribed transatlantic fund to invest in US, UK and European life science companies developing innovative therapeutics with potential to significantly improve human health

• Spruce Biosciences Raises $88 Million in Series B Financing, co-led by Omega Funds and Abingworth

  2/20/2020

  Proceeds to advance development of Tildacerfont in Congenital Adrenal Hyperplasia and other indications

• Abingworth appoints Neil Cooper as Chief Financial Officer

  11/13/2019

  He succeeds James Abell who is retiring after 21 years with the firm.

• Abingworth appoints Brian Gallagher, Jr as Partner

  9/21/2018

  Abingworth today announced that Brian Gallagher, PhD, will join Abingworth as a Partner based in the company’s Boston office.

• 

  Abingworth Closes on $315 Million Fund Aimed at Life Science Companies in Europe and the U.S.

  7/9/2018

  Abingworth Bioventures closed out its latest investment fund aimed at supporting life science companies with $315 million. The latest fund, ABV VII, will be used to support investments in Europe and the United States.

• VirionHealth Raises Series A Funding From Abingworth

  10/12/2017

• Takeda, Abingworth Infuse $100 Million Into a Tiny Biotech, Sealing an Option for M&A

  5/10/2017

• Abingworth Raises $105 Million For First Dedicated Clinical Co-Development Fund

  1/21/2016

• Life Sciences Investor, Abingworth Management Ltd., Nearing Final Close Of $374 Million+ Bioventure Fund

  2/27/2014

• Abingworth Management Ltd. Closes 300 Million Stg Life Sciences Fund

  1/29/2007

• Abingworth's Fund For Public Firms Has $53M First Closing

  7/27/2005